Apixaban and Ibrutinib: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Apixaban and Ibrutinib unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Apixaban interacts with Ibrutinib

Ibrutinib impairs platelet signalling through Bruton's tyrosine kinase inhibition, while apixaban inhibits factor Xa, producing additive bleeding risk.

What you should do

Avoid concurrent use when possible, particularly in patients with additional bleeding risks. If unavoidable, involve the relevant specialists and monitor closely for hemorrhage.

Key facts

Severity

Major — avoid combination

Mechanism

Ibrutinib impairs platelet signalling through Bruton's tyrosine kinase inhibition, while apixaban inhibits factor Xa, pr...

Action

Avoid concurrent use when possible, particularly in patients with additional bleeding risks. If unavoidable, involve the...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Apixaban and Ibrutinib together?

No — this combination should generally be avoided. Avoid concurrent use when possible, particularly in patients with additional bleeding risks. If unavoidable, involve the relevant specialists and monitor closely for hemorrhage.

What is the severity of this interaction?

The interaction between Apixaban and Ibrutinib is classified as Major — avoid combination. Ibrutinib impairs platelet signalling through Bruton's tyrosine kinase inhibition, while apixaban inhibits factor Xa, producing additive bleeding risk.

What should I do if I'm prescribed both?

Avoid concurrent use when possible, particularly in patients with additional bleeding risks. If unavoidable, involve the relevant specialists and monitor closely for hemorrhage. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.